The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Research Funding - Progenics (Inst)
A prospective phase II/III multicenter study of PSMA-targeted 18F-DCFPyL PET/CT imaging in patients with prostate cancer (OSPREY): A sub-analysis of regional and distant metastases detection rates at initial staging by 18F-DCFPyL PET/CT.
 
Frederic Pouliot
Honoraria - Amgen Astellas BioPharma; Bayer; Janssen; Sanofi
Consulting or Advisory Role - Amgen Astellas BioPharma; Bayer; Janssen; Progenics; Sanofi
Speakers' Bureau - Amgen Astellas BioPharma; Bayer; Sanofi
Research Funding - Amgen Astellas BioPharma; Bayer; Sanofi
Expert Testimony - Amgen Astellas BioPharma; Bayer; Sanofi
Travel, Accommodations, Expenses - Bayer; Sanofi
 
Peter Carroll
Honoraria - Intuitive Surgical
Consulting or Advisory Role - Nutcracker Therapeutics, Inc.
 
Stephan Probst
Stock and Other Ownership Interests - Progenics
Honoraria - Advanced Accelerator Applications; Bayer; Siemens
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer
Research Funding - Bayer (Inst); Progenics (Inst)
Travel, Accommodations, Expenses - Bayer
 
Kenneth J. Pienta
Leadership - CUE Biopharma
Stock and Other Ownership Interests - CUE Biopharma
Honoraria - Johnson & Johnson; Progenics
Consulting or Advisory Role - CUE Biopharma
Research Funding - Progenics
Travel, Accommodations, Expenses - CUE Biopharma
 
Steven P. Rowe
Research Funding - Progenics (Inst)
 
Lawrence Saperstein
Research Funding - Progenics (Inst)
 
Barry Siegel
Honoraria - Siemens (I)
Consulting or Advisory Role - AVID Radiopharmaceuticals; Curium Pharma; GE Healthcare; ImaginAb; Progenics
Research Funding - Blue Earth Diagnostics (Inst); ImaginAb (Inst); Progenics (Inst)
Travel, Accommodations, Expenses - ImaginAb; Progenics; Siemens (I)
 
Akash Patnaik
Honoraria - Clovis Oncology; Janssen Oncology; Merck; Prime Oncology
Consulting or Advisory Role - Janssen Oncology; Jounce Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Janssen Oncology (Inst); Progenics (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Clovis Oncology; Janssen Oncology; Merck; Prime Oncology
 
Mark A. Preston
No Relationships to Disclose
 
Ajjai Shivaram Alva
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Merck; Pfizer
Speakers' Bureau - AstraZeneca
Research Funding - Arcus Biosciences (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Merck Sharp & Dohme (Inst); Mirati Therapeutics (Inst); Progenics (Inst); Prometheus (Inst); Roche (Inst)
 
Michael A. Gorin
Research Funding - Progenics (Inst)
 
Michael J. Morris
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; Bayer; Blue Earth Diagnostics; Endocyte; ORIC Pharmaceuticals; Tokai Pharmaceuticals; Tolmar
Research Funding - Bayer (Inst); Corcept Therapeutics (Inst); Endocyte (Inst); Progenics (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bayer; Endocyte